Bridgeway Capital Management’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $329K | Sell |
|
|||||
|
2025
Q2 | $381K | Sell |
|
|||||
|
2025
Q1 | $266K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $134K | Sell |
|
|||||
|
2024
Q1 | $219K | Hold |
|
|||||
|
2023
Q4 | $74K | Hold |
|
|||||
|
2023
Q3 | $50.4K | Hold |
|
|||||
|
2023
Q2 | $123K | Hold |
|
|||||
|
2023
Q1 | $117K | Hold |
|
|||||
|
2022
Q4 | $45.5K | Hold |
|
|||||
|
2022
Q3 | $42K | Hold |
|
|||||
|
2022
Q2 | $57K | Hold |
|
|||||
|
2022
Q1 | $67K | Hold |
|
|||||
|
2021
Q4 | $71K | Sell |
|
|||||
|
2021
Q3 | $173K | Hold |
|
|||||
|
2021
Q2 | $219K | Sell |
|
|||||
|
2021
Q1 | $582K | Buy |
|
|||||
|
2020
Q4 | $83K | Sell |
|
|||||
|
2020
Q3 | $166K | Hold |
|
|||||
|
2020
Q2 | $158K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $62K | Hold |
|
|||||
|
2018
Q4 | $51K | Sell |
|
|||||
|
2018
Q3 | $93K | Hold |
|
|||||
|
2018
Q2 | $80K | Hold |
|
|||||
|
2018
Q1 | $75K | Sell |
|
|||||
|
2017
Q4 | $91K | Hold |
|
|||||
|
2017
Q3 | $118K | Hold |
|
|||||
|
2017
Q2 | $143K | Hold |
|
|||||
|
2017
Q1 | $135K | Hold |
|
|||||
|
2016
Q4 | $133K | Sell |
|
|||||
|
2016
Q3 | $198K | Hold |
|
|||||
|
2016
Q2 | $239K | Hold |
|
|||||
|
2016
Q1 | $248K | Hold |
|
|||||
|
2015
Q4 | $258K | Buy |
|
|||||
|
2015
Q3 | $301K | Buy |
|
|||||
|
2015
Q2 | $244K | Buy |
|
|||||
|
2015
Q1 | $251K | Buy |
|
|||||
|
2014
Q4 | $219K | Buy |
|